🔴 Indaptus Therapeutics is trading 5.18% down today amid a 58,895,000-share resale registration

Indaptus Therapeutics is trading 5.18% down at $1.10 amid continued volatility and supply concerns following its August 20, 2026 surge.

• An August 17 SEC prospectus registers up to 58,895,000 shares for resale by selling stockholders—approximately 44.2% of outstanding shares—with no proceeds going to the company.
• The stock fell from $1.38 on August 20 to $1.10 currently, while biotech and major indexes are higher, indicating company-specific supply concerns.
• No new company-specific announcement was identified for August 25, 2026.